Liquid-Filled Balloon

Intragastric balloons are endoscopically implanted balloons that can induce short-term and potentially long-term weight loss. Although its utilization has been widespread internationally for nearly 30 years, the United States Food and Drug Administration (FDA) recently approved the ORBERA® intragastric balloon in 2015. Clinical studies demonstrating good outcomes with this device reignited interest in this endoscopic therapy and has led to the appearance of alternative devices, which vary in design and insertion technique. Intragastric balloons have demonstrated both safety and efficacy in certain populations. It can be a viable option for patients with obesity who do not qualify for bariatric surgery or in high-risk patients to avoid the risk of surgery. As the technology advances, the ideal role of this therapy within the bariatric population will continue to evolve.